Subjects: CLINICAL trials; ATEZOLIZUMAB; TUMOR-infiltrating immune cellsAMERICA; MEXICO
Record details
Subjects: TYPE 2 diabetes; GLUCAGON-like peptide-1 agonists; ELI Lilly & Co.MEXICO; INDIA; JAPAN
Subjects: CHILDREN'S health; EPIDEMIOLOGY; CAUSES of deathMEXICO